Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
WBBA Newsletter Article [WIPO Article] [Fall 2013] [09/12/13]
Share |

 The Life Science Innovator 
  A WBBA Publication

In this issue...

Get Involved

WBBA Industry Working Groups

Connect with your peers to meet the unique challenges your Organization faces.

Communicators Group
(Open to ALL WBBA Members)

The goal of this group is to give people who are responsible for “getting the word out” for their respective organizations a closed-forum to discuss the unique issues, problems and challenges that face the people within these organizations who are charged with fulfilling the role of communications, public relations, marketing, community outreach and investor relations, whether by specific title or by having it as one of their responsibilities.

Join the group!

HR Group
(Open to WBBA Core & Institution Member HR professionals, no service providers)

You are invited to join over 50 of your HR colleagues from WBBA member companies, as we network, share ideas and exchange information about the challenges and issues we encounter while working in the biotechnology and biomedical fields. The Human Resources Group offers a variety of ways to connect with your colleagues. This is an excellent way to learn up-to-date information from professionals within our industry. You do not need to have an HR title in order to attend these meetings; you simply need to perform the human resources function for your company.

Join the group!

Clean Science Group
(Open to any WBBA member interested in clean science and sustainability)

The goal of the WBBA Clean Science Group is to have a variety of representatives of the region's life science community dialoguing about solutions to minimize the impact of our scientific pursuits on the region. We also want to educate each other on the systems that are currently available to reduce, reuse, and recycle, and the associated costs of such systems. Biotech is an industry reliant on sterile, one-use products to ensure high quality research. This process generates a lot of waste. Is biotech doing everything it can to reduce waste, and increase recycling? Are we sacrificing the health of our planet for the health of people? Is there a way to create science that is clean and healthy for both the planet and for the people we are trying to heal? Are you interested in dialoguing about creating clean science? If so, then join the WBBA Clean Science Group on LinkedIn. We would like to have participation from various groups in the lab including facilities, operations, and lab managers. Together, we can help heal people, progress science and have a healthy place to live.

Join the group!

Supply Chain Group
(Open to WBBA Core & Institution Member Supply Chain/Purchasing professionals, no service providers)

This group offers supply chain, purchasing, and sourcing professionals an opportunity to network and discuss the challenges they face and share best practices. If interested, please contact Blythe Price at

Join the group!

Facilities/Engineering Group
(Open to WBBA Core & Institution Member Facilities/Engineering professionals, no service providers)

This group offers Facilities and Engineering professionals an opportunity to network and discuss the challenges they face and share best practices. If interested, please contact Blythe Price at

Join the group!

Return to top

BIO Ventures for Global Health: A Bridge between Private Industry and Global Health Endeavors

BIO Ventures for Global Health (BVGH) was established in 2004 by the Biotechnology Industry Organization (BIO) to engage BIO member organizations in global health initiatives. Today, BVGH continues to work closely with BIO and many other organizations to develop programs, influence policies, create partnerships, and engage private industry to improve health worldwide. Earlier this year, BVGH relocated from San Francisco to the South Lake Union neighborhood in Seattle.

BVGH partnered with the World Intellectual Property Organization (WIPO) and plays a pivotal role as the Partnership Hub Administrator of the WIPO Re:Search consortium. The Consortium was launched in October 2011 by WIPO – a branch of the United Nations – in partnership with BVGH and eight global pharmaceutical companies. The aim of the consortium is to accelerate the development of new drugs, vaccines, and diagnostics for neglected tropical diseases, malaria, and tuberculosis. BVGH creates partnerships by connecting private industry’s assets and resources, such as compound libraries and expertise, with academic and nonprofit researchers possessing novel product discovery or development ideas. Since its inception, WIPO Re:Search membership has expanded to over 70 members, including 11 private industry organizations, 24 academic, and 19 nonprofit or government research institutions – 19 of which are located in developing world countries. As the Partnership Hub Administrator, BVGH fields requests from researchers, identifies member organizations able to fulfill these requests, and helps forge mutually beneficial collaborations. BVGH also proactively examines scientists’ current research and proposes novel collaboration opportunities to members. To date, BVGH has facilitated over 30 collaborations.  These collaborations include the sharing of compounds or compound libraries, the provision of computational chemistry, formulation, or structure-activity relationship advice, the hosting of developing world scientists at international industry or academic research institutions, and the sharing of data, samples, reagents and expertise.

BVGH also supports scientists advancing the development of products for diseases of poverty through its Funders Database – a comprehensive database of all open funding opportunities relevant to neglected disease research. This database summarizes and categorizes funding opportunities’ critical information, including program description, disease and product focus, stage of R&D, researcher and institute eligibility requirements, geographic restrictions, deadlines, contacts, and URL. By providing a single location that presents all relevant funding opportunities, the novel, sortable database allows scientists to minimize their time spent searching for the essential funding required to continue their much-needed research – thus enabling the researcher to commit his or her time and focus to important research activities.

BVGH is currently developing several new programs to improve health worldwide. One such project will increase African research institutions’ capacity for biomedical R&D. Starting in Nigeria, this program will develop a stronger biomedical R&D base and infrastructure by organizing research sabbaticals for Nigerian scientists at participating pharmaceutical and biotechnology companies, international academic, nonprofit, and government organizations. Successful applicants to this program will have the opportunity to spend a 4-12 month sabbatical performing experiments using cutting-edge tools to complete their own research projects, gaining skills and knowledge of industry drug discovery or development techniques, developing a foundation in clinical trial management, or learning about international intellectual property or regulatory practices. 

Pharmaceutical and biotechnology organizations have a great deal to offer, as well as to gain, through participation in global health initiatives. BVGH creates customized opportunities for private industry to contribute in meaningful ways to improving health and wellbeing in developing world countries. These initiatives inspire employees and build loyalty, while at the same time building future markets and improving the reputation of industry world-wide.

For more information about BVGH and its programs, please visit our website or send us an email.

Return to top

Return to newsletter main page


more Calendar

Pub Night in July

2016 Summer Social Round-up

Featured Partners
BioTech Primer Inc.BioTech Primer develops and delivers customized training to the Life Sciences community

Membership Management Software Powered by®  ::  Legal